Drug intelligence / Profile preview

umbilical cord blood megakaryocyte progenitor cells

Development stage: Unknown
Lead developer: Vitalant
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

Umbilical cord blood megakaryocyte progenitor cells is an investigational cell therapy consisting of progenitor cells derived from umbilical cord blood that are committed to the megakaryocyte lineage. Developed by the Institute of Transfusion Medicine at the Academy of Military Medical Sciences, this treatment is designed to address thrombocytopenia, a common side effect of radiotherapy and chemotherapy characterized by low platelet counts. By infusing these specialized progenitor cells, the therapy aims to bypass the early stages of hematopoiesis and provide a more immediate source of cells that can mature into platelets, thereby accelerating hematopoietic recovery and reducing the risk of bleeding complications in cancer patients.

Other names: Injection of Umbilical Cord Blood Megakaryocyte Progenitor CellsMegakaryocyte Progenitor Cells from Umbilical Cord Blood

Beyond the preview

Go deeper on umbilical cord blood megakaryocyte progenitor cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord blood megakaryocyte progenitor cells.

Explore the full profile